You are here

Pharmaceutical Approval Update November 2009

Marvin M. Goldenberg, PhD, RPh, MS
PDF version: 
Topics include pralatrexate (Folotyn) for lymphoma; telavancin (Vibativ) for skin infections; and bepotastine besilate (Bepreve), an eyedrop for conjunctivitis.